Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1541157 · AKTX

Akari Therapeutics Plc

Filing with the SEC SEC-reporting company Tampa, FL Nasdaq
An email when it files something new with the SEC. Your account

What this means

  • Exchange listing at riskOn Nov 26, 2025 the company disclosed a notice from its exchange (Item 3.01). Exchanges usually give a period to regain compliance before delisting.
  • Net loss in 2025Net loss of $17.3M for the year (2024: −$19.8M).
  • Private capital raiseOn Jun 3, 2026 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Net income (loss)−$17.3M−$19.8M
Total assets$47.9M$50.6M
Total liabilities$19.6M$28.3M
Stockholders’ equity$28.3M$22.2M
Cash and equivalents$5.2M$0

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Akari Therapeutics Plc
Formerly: Celsus Therapeutics Plc.
CIK
0001541157
Tickers
AKTX
Kind of filer
SEC-reporting company
Non-accelerated filer; Smaller reporting company
Status
Filing with the SEC
State of incorporation
United Kingdom
Business address
Tampa, Florida
Industry (SIC)
2834 · Pharmaceutical preparations
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Director or officer change: CEO change
    Form 8-K · items 5.02, 9.01 · filed Oct 1, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 13, 2026 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jun 3, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 19, 2026 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed May 18, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed May 8, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 30, 2026 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jan 23, 2026 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Nov 26, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Nov 17, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Oct 24, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Oct 23, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 3.02, 5.02, 9.01 · filed Aug 29, 2025 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Aug 29, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 13, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 5.07, 9.01 · filed Jul 1, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 15, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 14, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 16, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Apr 15, 2025 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Mar 31, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Mar 20, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 18, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 16, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02 · filed Dec 12, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 19, 2024 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Nov 15, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 3.01, 3.02, 5.02, 7.01, 9.01 · filed Nov 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 1.01, 2.01, 3.01, 3.02, 5.02, 7.01, 9.01 · filed Nov 14, 2024 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 3.01, 3.02, 5.02, 7.01, 9.01 · filed Nov 14, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Oct 4, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Sep 18, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Aug 19, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 19, 2024 · filing
  • Late quarterly report notice: Quarterly report (10-Q) will be late
    Form NT 10-Q · filed Aug 15, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jun 18, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Jun 7, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 9.01 · filed Jun 5, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed May 16, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 2.05, 5.02 · filed May 7, 2024 · filing
  • Restructuring or layoffs
    Form 8-K · items 2.05, 5.02 · filed May 7, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed May 1, 2024 · filing
  • Notice of delisting or listing-rule failure
    Form 8-K · items 3.01 · filed Apr 11, 2024 · filing
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Apr 1, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Mar 29, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jan 9, 2024 · filing
  • Private raise (Form D)
    Form D · items 06c · filed Oct 19, 2023 · filing
  • Annual report (20-F): 20-F for the period ended Dec 31, 2022
    Form 20-F · filed May 1, 2023 · filing